Pediatric News
Cognoa’s Machine Learning Software for Autism Diagnosis gets FDA Nod
FDA has authorized Cognoa’s machine learning-based software for use in the diagnosis of autism spectrum disorder (ASD) in children aged 18 months
Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. Pediatric research, however, has led to dramatic changes in child health. Children have faced seemingly insurmountable challenges from illnesses, genetic diseases, and environmental influences. In 1975, a childhood diagnosis of acute lymphocytic leukemia (ALL) often meant certain death within five years, and […]
FDA has authorized Cognoa’s machine learning-based software for use in the diagnosis of autism spectrum disorder (ASD) in children aged 18 months
High levels of neurofilament light (NfL), a brain injury biomarker, during the first weeks of postnatal life are associated with
For patients with diabetes, diabetic retinopathy is a potential major complication. It is also one that can be mitigated with
Copyright © 2024, A4M. All trademarks, registered or unregistered, are the property of their respective owners.